Rick Wise
Stock Analyst at Stifel
(4.44)
# 269
Out of 4,783 analysts
232
Total ratings
63.49%
Success rate
12.25%
Average return
Main Sectors:
Stocks Rated by Rick Wise
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KIDS OrthoPediatrics | Maintains: Buy | $40 → $32 | $24.75 | +29.29% | 6 | Mar 5, 2025 | |
| LIVN LivaNova | Maintains: Buy | $72 → $60 | $39.62 | +51.44% | 6 | Feb 26, 2025 | |
| AORT Artivion | Maintains: Buy | $33 → $30 | $24.50 | +22.45% | 6 | Feb 25, 2025 | |
| ATRC AtriCure | Maintains: Buy | $36 → $48 | $34.37 | +39.66% | 13 | Feb 13, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $115 → $120 | $100.80 | +19.05% | 17 | Feb 10, 2025 | |
| CNMD CONMED | Maintains: Buy | $72 → $75 | $59.85 | +25.31% | 10 | Feb 6, 2025 | |
| EW Edwards Lifesciences | Upgrades: Buy | $75 → $90 | $71.19 | +26.42% | 23 | Jan 30, 2025 | |
| SYK Stryker | Maintains: Buy | $400 → $440 | $367.54 | +19.71% | 16 | Jan 29, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Buy | $130 → $138 | $112.15 | +23.05% | 14 | Jan 23, 2025 | |
| JNJ Johnson & Johnson | Maintains: Hold | $170 → $155 | $163.13 | -4.98% | 6 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $135 | $131.35 | +2.78% | 19 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $525 → $610 | $507.90 | +20.10% | 17 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $170 → $190 | $168.47 | +12.78% | 14 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $38 | $33.70 | +12.76% | 8 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $7 → $8 | $8.37 | -4.42% | 8 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $16 | $6.79 | +135.64% | 4 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $82 | $75.51 | +8.59% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $102 | $81.66 | +24.91% | 2 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $85 → $87 | $88.98 | -2.23% | 11 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $270 → $280 | $228.71 | +22.43% | 7 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $9 → $12 | $6.19 | +93.86% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $59 → $75 | $83.92 | -10.63% | 1 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $17 → $24 | $19.81 | +21.15% | 7 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $390 → $90 | $12.11 | +643.19% | 4 | Oct 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $25 | $14.33 | +74.46% | 4 | Jun 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $103 → $112 | $58.23 | +92.34% | 5 | Oct 2, 2020 |
OrthoPediatrics
Mar 5, 2025
Maintains: Buy
Price Target: $40 → $32
Current: $24.75
Upside: +29.29%
LivaNova
Feb 26, 2025
Maintains: Buy
Price Target: $72 → $60
Current: $39.62
Upside: +51.44%
Artivion
Feb 25, 2025
Maintains: Buy
Price Target: $33 → $30
Current: $24.50
Upside: +22.45%
AtriCure
Feb 13, 2025
Maintains: Buy
Price Target: $36 → $48
Current: $34.37
Upside: +39.66%
Boston Scientific
Feb 10, 2025
Maintains: Buy
Price Target: $115 → $120
Current: $100.80
Upside: +19.05%
CONMED
Feb 6, 2025
Maintains: Buy
Price Target: $72 → $75
Current: $59.85
Upside: +25.31%
Edwards Lifesciences
Jan 30, 2025
Upgrades: Buy
Price Target: $75 → $90
Current: $71.19
Upside: +26.42%
Stryker
Jan 29, 2025
Maintains: Buy
Price Target: $400 → $440
Current: $367.54
Upside: +19.71%
Zimmer Biomet Holdings
Jan 23, 2025
Maintains: Buy
Price Target: $130 → $138
Current: $112.15
Upside: +23.05%
Johnson & Johnson
Jan 23, 2025
Maintains: Hold
Price Target: $170 → $155
Current: $163.13
Upside: -4.98%
Jan 23, 2025
Maintains: Buy
Price Target: $130 → $135
Current: $131.35
Upside: +2.78%
Dec 5, 2024
Maintains: Buy
Price Target: $525 → $610
Current: $507.90
Upside: +20.10%
Nov 22, 2024
Reiterates: Buy
Price Target: $170 → $190
Current: $168.47
Upside: +12.78%
Nov 11, 2024
Maintains: Buy
Price Target: $46 → $38
Current: $33.70
Upside: +12.76%
Nov 6, 2024
Maintains: Hold
Price Target: $7 → $8
Current: $8.37
Upside: -4.42%
Oct 31, 2024
Maintains: Buy
Price Target: $17 → $16
Current: $6.79
Upside: +135.64%
Oct 8, 2024
Initiates: Buy
Price Target: $82
Current: $75.51
Upside: +8.59%
Sep 30, 2024
Maintains: Buy
Price Target: $100 → $102
Current: $81.66
Upside: +24.91%
Aug 21, 2024
Maintains: Hold
Price Target: $85 → $87
Current: $88.98
Upside: -2.23%
Jul 26, 2024
Maintains: Buy
Price Target: $270 → $280
Current: $228.71
Upside: +22.43%
Jul 16, 2024
Upgrades: Buy
Price Target: $9 → $12
Current: $6.19
Upside: +93.86%
Apr 26, 2024
Upgrades: Buy
Price Target: $59 → $75
Current: $83.92
Upside: -10.63%
Feb 5, 2024
Maintains: Hold
Price Target: $17 → $24
Current: $19.81
Upside: +21.15%
Oct 13, 2023
Maintains: Buy
Price Target: $390 → $90
Current: $12.11
Upside: +643.19%
Jun 21, 2023
Reiterates: Hold
Price Target: $25
Current: $14.33
Upside: +74.46%
Oct 2, 2020
Maintains: Hold
Price Target: $103 → $112
Current: $58.23
Upside: +92.34%